TB-500 and Thymosin Beta-4: Actin Binding and Regenerative Research

TB-500 is a synthetic peptide fragment of Thymosin Beta-4 (Tβ4), one of the most abundant intracellular peptides in mammalian cells. While native Tβ4 is a 44-amino-acid protein, the TB-500 fragment isolates the regions most directly associated with G-actin sequestration and cell-migration signaling.

The KLKKTET motif

Within Tβ4, the heptapeptide sequence KLKKTET is the canonical actin-binding region. Mutational studies have shown that this motif is necessary, though not always sufficient, for the migratory and regenerative effects observed with the full peptide. It is the most-characterized functional sequence in the broader thymosin literature.

Where TB-500 has been studied

• Cardiac infarct models — preservation of left-ventricular function via epicardial progenitor recruitment
• Dermal wound-healing models — accelerated re-epithelialization and reduced fibrotic scarring
• Corneal injury — reduced inflammatory infiltrate and improved epithelial closure
• Equine musculoskeletal studies — a substantial veterinary literature base

Mechanistic threads

Beyond actin sequestration, TB-500 modulates inflammation via downregulation of NF-κB signaling, promotes angiogenesis through VEGF-related pathways, and supports stem-cell migration toward injury sites. Together, these effects describe a tissue-protective rather than purely proliferative profile.

Handling and storage

Lyophilized TB-500 is stable at -20°C for extended periods. Reconstituted solutions should be stored at 2–8°C and used within ~14 days for best peptide integrity. For chronic-dosing protocols, single-use aliquots are strongly recommended.

TB-500 is intended for laboratory research only. Not for human use.